FDA approves Lantheus’ VIALMIXRFID device for DEFINITY

Lantheus’ DEFINITY Vial for injectable suspension is an ultrasound enhancing agent indicated for use in patients with suboptimal echocardiograms. Credit: Patrick J Lynch, medical illustrator.



  • Lantheus